Jeffrey M. Rosen
Oncology · 2003–2011
A researcher in the Science corpus: 7 papers; trusts 7 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 96 citations into it; #982 of 1,698 by trust here, #445 by citations
- Molecular Biology — 83 citations into it
- Immunology — 13 citations into it
Whom Jeffrey M. Rosen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Jeffrey M. Rosen overall
Papers from Jeffrey M. Rosen's perspective
Ordered by how strongly the researchers Jeffrey M. Rosen trusts endorse each paper. Same corpus, a different order for every researcher.
- In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. (Genes & Development)
- Stem cells, cancer, and cancer stem cells (Nature)
- The epithelial-mesenchymal transition generates cells with properties of stem cells. (Cell)
- Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. (Cancer Research)
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. (Genes & Development)
- Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. (Cell)
- The prognostic role of a gene signature from tumorigenic breast-cancer cells. (New England Journal of Medicine)
- Smoldering and polarized inflammation in the initiation and promotion of malignant disease. (Cancer Cell)
- Molecular definition of breast tumor heterogeneity. (Cancer Cell)
- Identification of selective inhibitors of cancer stem cells by high-throughput screening (Cell)
Their papers
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes (2010) — 1,021 citations
- The Increasing Complexity of the Cancer Stem Cell Paradigm (2009) — 728 citations
- The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo (2011) — 645 citations
- Modelling breast cancer: one size does not fit all (2007) — 712 citations
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features (2009) — 1,423 citations
- Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. (2008) — 1,866 citations
- Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. (2003) — 2,342 citations